Cephalon, Inc. v. Watson Pharmaceuticals, Inc.

Procedural entryThis page is a short order in Cephalon, Inc. v. Watson Pharmaceuticals, Inc.. Read the opinion of the Court — 707 F.3d 1330
Court of Appeals for the Federal Circuit·Decided February 22, 2012·No. 2011-1325·Unpublished

Opinion

NOTE: This order is nonprecedential United States Court of Appeals for the FederaI Circuit CEPHALON, INC. AND CIM.A LABS, INC., Plaintiffs-Appellants, ' V. WATSON PHARMACEUTICALS, INC., WATSON LABORATORIES, INC., AND WATSON PHARMA, INC., Defendan.ts~Appellees. 2011-1325 Appea1 from the United States District Court for the District of De1aware in case no. 08-CV-0330, Judge Sue L. R0binSon. ON MOTION ORDER Wats0n Pharmaceutica1s, Inc., Wats0n Lab0ratories, Inc., and Wats0n Pharma, Inc., move for a 30-day exten- sion of time, until April 4, 2012, to file their opening brief due to settlement negotiati0ns. Up0n consideration thereof,

CEP ccc s21 HALON V. WATSON PHARMA IT ls ORDERED THAT: The motion is granted FEB 2 2 2012 Date Wi1liarn F. Lee, Esq. n J ames K. Stronski, Esq. 2 FOR THE COURT fsi J an H0rba]y J an H0rba1y C1erk U.S. C0UR`|IF(lJlFF\l?PEALS FOR THE FEDERAL ClBCUlT FEB 22 2012 _ .\ANn0naAw CLERK

Free access — add to your briefcase to read the full text and ask questions with AI

Cephalon, Inc. v. Watson Pharmaceuticals, Inc., (Fed. Cir. 2012).

Cephalon, Inc. v. Watson Pharmaceuticals, Inc. (Cephalon, Inc. v. Watson Pharmaceuticals, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.